Mt. Pleasant, SC, United States of America

Shibnath Ghatak


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Mount Pleasant, SC (US) (2012)
  • Mt. Pleasant, SC (US) (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shibnath Ghatak: Innovator in Cancer Treatment

Introduction

Shibnath Ghatak is a notable inventor based in Mt. Pleasant, SC (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented technologies. With a total of 2 patents, Ghatak is recognized for his work in developing methods to combat multi-drug resistance in cancer cells.

Latest Patents

Ghatak's latest patents focus on "Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers." These pharmaceutical compositions aim to sensitize multi-drug resistant cancer or radiation resistant cancer cells to chemotherapeutic agents. The compositions include ligands of hyaluronan receptors, glycosaminoglycans such as hyaluronan oligomers and their derivatives, hyaluronan binding proteins, antibodies specific for hyaluronan receptors, hyaluronan mimetics, inhibitors of hyaluronan synthesis, and stimulators of hyaluronan degradation.

Career Highlights

Shibnath Ghatak is affiliated with Tufts University, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve treatment outcomes for patients facing multi-drug resistant cancers.

Collaborations

Ghatak collaborates with esteemed colleagues such as Bryan P Toole and Suniti Misra, contributing to a dynamic research environment focused on innovative cancer treatments.

Conclusion

Shibnath Ghatak's contributions to the field of cancer treatment through his patented inventions highlight his commitment to addressing critical challenges in medicine. His work continues to pave the way for advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…